Lyra Therapeutics (LYRA) Return on Equity [ROE] (2020 - 2025)
Lyra Therapeutics' Return on Equity [ROE] came in at -6594.98% for FY2025, down 6409.99 percentage points from -184.99% in FY2024.
Powered by 
Analysis
Lyra Therapeutics (LYRA) Return on Equity [ROE] (2020 - 2025) Analysis & Trends
Going back to FY2021, Lyra Therapeutics' Return on Equity [ROE] data covers 5 years.
- Return on Equity [ROE] carries a four-year change of -6515.00 percentage points (FY2021 to FY2025).
- The FY2025 figure represents the lowest annual Return on Equity [ROE] in data going back to FY2021.
- Per Business Quant, earlier years put Return on Equity [ROE] at -184.99% in FY2024 (-111.33 pp), -73.67% in FY2023 (+22.41 pp), -96.08% in FY2022 (-16.10 pp) and -79.98% in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Lyra Therapeutics | 266,232.31 | 266,232.31 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,413.76% |
| Mar 31, 2025 | -1,028.45% |
| Dec 31, 2024 | -580.11% |
| Sep 30, 2024 | -378.37% |
| Jun 30, 2024 | -186.93% |
| Mar 31, 2024 | -82.52% |
| Dec 31, 2023 | -72.19% |
| Sep 30, 2023 | -67.55% |
| Jun 30, 2023 | -73.92% |
| Mar 31, 2023 | -81.19% |
| Dec 31, 2022 | -63.53% |
| Sep 30, 2022 | -54.80% |
| Jun 30, 2022 | -78.68% |
| Mar 31, 2022 | -165.43% |
| Dec 31, 2021 | -106.78% |
| Sep 30, 2021 | -70.53% |
| Jun 30, 2021 | -51.49% |
| Mar 31, 2021 | -36.18% |
| Dec 31, 2020 | -28.48% |
| Sep 30, 2020 | -23.20% |
API Access
Lyra Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LYRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LYRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LYRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();